Domsicova M, Korcekova J, Poturnayova A, Breier A
Int J Mol Sci. 2024; 25(13).
PMID: 38999943
PMC: 11240909.
DOI: 10.3390/ijms25136833.
DeRosa M, Lin A, Mallikaratchy P, McConnell E, McKeague M, Patel R
Nat Rev Methods Primers. 2023; 3.
PMID: 37969927
PMC: 10647184.
DOI: 10.1038/s43586-023-00247-6.
Rabiee N, Chen S, Ahmadi S, Veedu R
Theranostics. 2023; 13(15):5183-5206.
PMID: 37908725
PMC: 10614690.
DOI: 10.7150/thno.85419.
LaFargue C, Amero P, Noh K, Mangala L, Wen Y, Bayraktar E
Nat Commun. 2023; 14(1):2407.
PMID: 37100807
PMC: 10133315.
DOI: 10.1038/s41467-023-36910-5.
Zhu Y, Hart G
Cell. 2023; 186(2):428-445.e27.
PMID: 36626902
PMC: 9868088.
DOI: 10.1016/j.cell.2022.12.016.
Efficacy of newly discovered DNA aptamers targeting AXL in a lung cancer cell with acquired resistance to Erlotinib.
Hwang J, Hur J, Kim Y, Im J, Jin S, Ryu S
Transl Cancer Res. 2022; 10(2):1025-1033.
PMID: 35116429
PMC: 8798984.
DOI: 10.21037/tcr-20-2447.
Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum.
Tapia-Alveal C, Olsen T, Worgall T
Commun Biol. 2020; 3(1):781.
PMID: 33335255
PMC: 7747622.
DOI: 10.1038/s42003-020-01515-x.
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells.
Affinito A, Quintavalle C, Esposito C, Roscigno G, Vilardo C, Nuzzo S
Mol Ther Nucleic Acids. 2019; 18:99-109.
PMID: 31541799
PMC: 6796606.
DOI: 10.1016/j.omtn.2019.08.015.
Screening of aptamers and their potential application in targeted diagnosis and therapy of liver cancer.
Zhang G, Zhong L, Yang N, Zhao Y
World J Gastroenterol. 2019; 25(26):3359-3369.
PMID: 31341361
PMC: 6639558.
DOI: 10.3748/wjg.v25.i26.3359.
Aptamer-Modified Magnetic Nanosensitizer for In Vivo MR Imaging of HER2-Expressing Cancer.
Heo D, Ku M, Kim J, Yang J, Suh J
Nanoscale Res Lett. 2018; 13(1):288.
PMID: 30229394
PMC: 6143495.
DOI: 10.1186/s11671-018-2682-3.
Key Aspects of Nucleic Acid Library Design for in Vitro Selection.
Vorobyeva M, Davydova A, Vorobjev P, Venyaminova A
Int J Mol Sci. 2018; 19(2).
PMID: 29401748
PMC: 5855692.
DOI: 10.3390/ijms19020470.
Fit for the Eye: Aptamers in Ocular Disorders.
Drolet D, Green L, Gold L, Janjic N
Nucleic Acid Ther. 2016; 26(3):127-46.
PMID: 26757406
PMC: 4900223.
DOI: 10.1089/nat.2015.0573.
Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.
Aravind A, Yoshida Y, Maekawa T, Kumar D
Drug Deliv Transl Res. 2015; 2(6):418-36.
PMID: 25787323
DOI: 10.1007/s13346-012-0104-0.
Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents.
Rohloff J, Gelinas A, Jarvis T, Ochsner U, Schneider D, Gold L
Mol Ther Nucleic Acids. 2014; 3:e201.
PMID: 25291143
PMC: 4217074.
DOI: 10.1038/mtna.2014.49.
DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.
Iida J, Clancy R, Dorchak J, Somiari R, Somiari S, Cutler M
PLoS One. 2014; 9(2):e88712.
PMID: 24586375
PMC: 3929491.
DOI: 10.1371/journal.pone.0088712.
From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.
Cibiel A, Nguyen Quang N, Gombert K, Theze B, Garofalakis A, Duconge F
PLoS One. 2014; 9(1):e87002.
PMID: 24489826
PMC: 3906106.
DOI: 10.1371/journal.pone.0087002.
Selecting Molecular Recognition. What Can Existing Aptamers Tell Us about Their Inherent Recognition Capabilities and Modes of Interaction?.
Zhang Q, Landgraf R
Pharmaceuticals (Basel). 2013; 5(5):493-513.
PMID: 24281560
PMC: 3763653.
DOI: 10.3390/ph5050493.
Development of RNA aptamers targeting Ebola virus VP35.
Binning J, Wang T, Luthra P, Shabman R, Borek D, Liu G
Biochemistry. 2013; 52(47):8406-19.
PMID: 24067086
PMC: 3909728.
DOI: 10.1021/bi400704d.
Escort aptamers: new tools for the targeted delivery of therapeutics into cells.
Davydova A, Vorobjeva M, Venyaminova A
Acta Naturae. 2012; 3(4):12-29.
PMID: 22649701
PMC: 3347615.
5'-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity.
Hwang S, Sun H, Lee K, Oh B, Cha Y, Kim B
Nucleic Acids Res. 2011; 40(6):2724-33.
PMID: 22127865
PMC: 3315321.
DOI: 10.1093/nar/gkr1098.
